Trial Profile
An Open-label, Single Dose, Randomised, Cross-over Study to Determine the Fasted State pharmacokinetics of Oxycodone from Oxycodone Tamper Resistant (OTR) Tablet 40 mg and OXYCONTIN Tablet 40 mg in Chinese Subjects with Chronic Pain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary) ; Naltrexone
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Mundipharma (China) Pharmaceutical
- 02 Nov 2019 Status changed from not yet recruiting to completed as per the results published in the Clinical Drug Investigation
- 02 Nov 2019 Results assessing pharmacokinetics of oxycodone tamper resistant tablet published in the Clinical Drug Investigation
- 23 Jul 2018 New trial record